/Companies

KeborMed

Cleveland, US · Delaware corporation · 1 known investors

Find your way into KeborMed

Sign up to see every warm intro you have to KeborMed

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the KeborMed team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Kebormed develops medical devices spanning multiple medical fields and conditions, working at the intersection of medicine and technology. The company operates in the medtech and digital health space.

Founders & leadership

RIRadu Iancu
Radu IancuFounder & CEORadu Iancu holds an MD in Cardiology and a PhD in Biomedical Engineering, with an early background in programming. He founded KeborMed to develop regulated medical device infrastructure for digital health teams.
WGWarren Goldenberg
Warren GoldenbergChief Operating OfficerHe previously served as CEO of three life sciences companies—Imalux, CardioInsight (acquired by Medtronic in 2015), and Fluence Therapeutics—and spent over 30 years as a partner at law firm Hahn Loeser and Parks focusing on technology and life sciences transactions including M&A, financing, and clinical trials.
NFNikolaos Fikas
Nikolaos FikasChief Security Officer
CN
Chitra NadigDirector of Quality & Regulatory
AP
Ana-Maria Piso-GrigoreR&D Lead

Investors · 1

Reported raises · per SEC filings

Form D private placements

$2.9M disclosed across 3 rounds · 2018–2022

▶$1.9MraisedMay 2022 · 7 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Radu IancuExecutive Officer, Director, Promoter
  • Robert ImmermanDirector
  • Warren GoldenbergExecutive Officer, Director, Promoter
Offering amount
$2.5M
Amount sold
$1.9M
Minimum investment
$10K
Proceeds to insiders
$200K
First sale
Aug 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$845KraisedMay 2022 · 5 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Warren GoldenbergExecutive Officer, Director, Promoter
  • Robert ImmermanDirector
  • Radu IancuExecutive Officer, Director, Promoter
Offering amount
$1.5M
Amount sold
$845K
Minimum investment
$50K
Proceeds to insiders
$100K
First sale
May 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$125KraisedJun 2018 · 2 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Radu IancuExecutive Officer, Director, Promoter
  • Warren GoldenbergExecutive Officer, Director, Promoter
Offering amount
$500K
Amount sold
$125K
Minimum investment
$10K
Proceeds to insiders
$50K
First sale
Jun 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does KeborMed do?
Kebormed develops medical devices spanning multiple medical fields and conditions, working at the intersection of medicine and technology. The company operates in the medtech and digital health space.
Who founded KeborMed?
KeborMed was founded by Radu Iancu.
Who are KeborMed's investors?
KeborMed's investors include Third Act Ventures.
How much funding has KeborMed raised?
KeborMed has disclosed $2.9M raised across 3 rounds.
Where is KeborMed headquartered?
KeborMed is headquartered in Cleveland, US.